MedTrace Logo

Menopause Sample Collection

NCT04853472 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 151

Last updated 2023-12-13

No results posted yet for this study

Summary

This study will provide daily urine samples from women during early and late stage peri-menopause as well as post-menopause over the course of three calendar months in order to maintain the SPD sample bank.

Urine samples will be received in the clinical laboratory and aliquoted into 2.25ml amounts and stored at -80˚C until required.

Symptom information will also be recorded to determine whether there are any noticeable physiological changes that can be related to stage of the menopause.

Conditions

Sponsors & Collaborators

  • SPD Development Company Limited

    lead INDUSTRY

Principal Investigators

  • Raniero Zazzeroni · SPD Development Company

  • Jackie Boxer · SPD Development Company

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-19
Primary Completion
2022-01-05
Completion
2023-03-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04853472 on ClinicalTrials.gov